Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are ATAT, VRT, CORT, QFIN, ADMA.
Investors can contact the law firm at no cost to learn more about recovering their losses
NEW YORK, NY / ACCESSWIRE / October 10, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the
Block & Leviton is investigating ADMA Biologics for potential securities law violations. Investors who have lost money in ADMA should contact the firm.
The US equity benchmarks were little changed after opening significantly lower on Thursday, following a hotter-than-expected inflation report.  At the time of writing, the Dow Jones Industrial Averag
The latest trading day saw Adma Biologics (ADMA) settling at $20.33, representing a -1.91% change from its previous close.
If you're like most investors — you assume AI giant Nvidia is the best stock of the year. But 2024's major champ isn't even in the S&P 500.

New Strong Buy Stocks for October 7th

07:16am, Monday, 07'th Oct 2024
ADMA, VERX, TRGP, EBMT and TALO have been added to the Zacks Rank #1 (Strong Buy) List on October 7, 2024.
In the most recent trading session, Adma Biologics (ADMA) closed at $19.50, indicating a -1.37% shift from the previous trading day.
Here is how Adma Biologics (ADMA) and Assembly Biosciences (ASMB) have performed compared to their sector so far this year.

ADMA Biologics: Riding High On ASCENIV's Success

07:30am, Wednesday, 02'nd Oct 2024
ADMA Biologics reported $107.2 million in Q2 2024 revenue, a 78% year-over-year increase, with ASCENIV being the primary growth driver. ASCENIV now contributes over 50% of ADMA's total revenue, with s
Adma Biologics (ADMA) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through
This biopharma stock has gained around 330% so far this year and is near record highs.
In the closing of the recent trading day, Adma Biologics (ADMA) stood at $19.44, denoting a -0.26% change from the preceding trading day.
ADMA stock surges 76.2% in three months on strong performance and high growth prospects. It recently hit its 52-week high with more room for growth.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE